New orphan drug (clobazam-Onfi) approved for Lennox-Gastaut seizures

Some types of seizures are difficult to control. This is certainly true of Lennox-Gastaut syndrome. the FDA has approved cobazam (Onfi) as add-on therapy to treat seizures in children 2 years or older and adults. This is called an orphan drug since it is approved to treat a disease or condition that impacts 200,000 people or less.

Lennox-Gastaut is a particularly challenging kind of epilepsy for those suffering with the condition as well for clinicians trying to treat it. This syndrome usually starts at roughly 4 years of age and can also be caused by head injuries, central nervous system infections and metabolic conditions.

Additional information can be found at www.fda.gov

Approval Date: 
Mon, 10/24/2011
Company
Lundbeck

Contact Us
 

Our Location

Office Hours
Monday:9:00 AM - 5:00 PM
Tuesday:9:00 AM - 5:00 PM
Wednesday:9:00 AM - 5:00 PM
Thursday:9:00 AM - 5:00 PM
Friday:9:00 AM - 5:00 PM
Saturday:Closed
Sunday:Closed